Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan plus amoxicillin dual therapy for Helicobacter pylori eradication in central China
ChiCTR2400087205Phase 4Recruiting
- Sponsor
- Henan Provincial People's Hospital
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of vonoprazan in Helicobacter pylori infection (4 arms), sponsored by Henan Provincial People's Hospital. Primary endpoint: eradication rate. Started Jul 2024; status: recruiting.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2400087205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400087205.